LHON stands for Leber’s Hereditary Optic Neuropathy. In LHON the optic nerve is particularly vulnerable to mitochondrial defects because of the high-energy requirements and the need to keep the retina transparent to light.
LHON has a prevalence of 1/25,000 to 1/50,000 and it is more frequent in males.
Every year we work to draw more attention to this condition. Help us shine a light on LHON.
This year LHON Awareness was on Saturday 19 September.
Library of past LHON related webinars
Each year we host a live webinar on issues related to LHON and mitochondrial disease. These webinars include the voices of those affected by mito conditions, researchers, clinicians and pharmaceutical companies.
Each year we host a live webinar on issues related to LHON and mitochondrial disease.
Whether you’re recently diagnosed with LHON or seeking to broaden your understanding of this condition, you may find these videos useful to watch.
2026: LHON and Best Practices
2025: Exploring the Power of Nutrition in Mitochondrial Diseases
2024: Gene Therapy: Where are we now?
2023: LHON and the Family
2022: Research and Rehabilitation
2021: The Importance of Technology for LHON Patients
Technology can make an enormous difference to the quality of life for LHON sufferers. Watch IMP Chair Kira Mann along with board member, Paula Morandi, discuss this with technology expert Michele Landolfo, from the Cavazz Blind Institute of Bolgna.
2020: One Condition Many Stories
Jo de Bry from IMP hosts 10 different people affected by LHON as they share their stories of diagnosis and day to day life with the condition.